Product Information
PRADAXA 110 MG CAPSULE is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $3.1665 per EA under NDC 00597010860. Its NADAC has been published 462 times since Sep 21, 2016.
FDA first approved this application on Oct 19, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
110 mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597010860
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA022512FDA Approved
10/19/2010
TE Code
AB
On Market Since
11/23/2015
Pharmacological Classes
Price Statistics
The NADAC for PRADAXA 110 MG CAPSULE has been published 462 times since Sep 21, 2016, and over the history we have for it it has declined 43.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1665 per EA |
|---|---|
| All-time high | $7.9069 (Mar 15, 2023) |
| All-time low | $3.1586 (Dec 18, 2024) |
| 52-week high | $3.1740 |
| 52-week low | $3.1608 |
| Median price | $6.4575 |
| Average price | $5.9572 |
| Largest weekly change | -60.0% (Apr 17, 2024) |
| Weeks tracked | 462 |
| Tracking since | Sep 21, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PRADAXA 110 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PRADAXA 110 MG CAPSULE, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $3.1665 per EA (NDC 00597010860), effective Aug 19, 2026.
How has the price of PRADAXA 110 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PRADAXA 110 MG CAPSULE has declined 43.9%. It has been tracked across 462 weekly CMS publications since Sep 21, 2016.
What are the highest and lowest recorded NADAC prices for PRADAXA 110 MG CAPSULE?
Since Sep 21, 2016, the NADAC for PRADAXA 110 MG CAPSULE has ranged from a low of $3.1586 (Dec 18, 2024) to a high of $7.9069 (Mar 15, 2023), with a median of $6.4575 per EA.
Are there cheaper alternatives to PRADAXA 110 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PRADAXA 110 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures PRADAXA 110 MG CAPSULE?
PRADAXA 110 MG CAPSULE (NDC 00597010860) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.